← Back to Search

HOLA Program for Preventing Cognitive Decline (HOLA-CD Trial)

N/A
Waitlist Available
Led By Daniel Jimenez, Ph.D.
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
are age 50+;
volunteer informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 16 weeks
Awards & highlights

HOLA-CD Trial Summary

This trial will test different ways of preventing cognitive decline in HIV+ Latino adults.

Who is the study for?
This trial is for Latino adults over 50 living with HIV who have their viral load under control. They must be able to walk and give informed consent, but can't join if they're undergoing cancer treatment, have significant hearing or vision loss, a history of serious brain trauma, any neurodegenerative diseases like Alzheimer's, or conditions that make exercise unsafe.Check my eligibility
What is being tested?
The study tests the 'Happy Older Latinos are Active (HOLA)' program to prevent memory loss and decline in mental function among older Latino adults with HIV. It aims to find effective strategies for maintaining cognitive health in this population.See study design
What are the potential side effects?
Since HOLA focuses on lifestyle changes and physical activity to improve cognitive function, side effects may include typical exercise-related issues such as muscle soreness or strain. However, participants with contraindications to physical activity are excluded from the trial.

HOLA-CD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.
Select...
I have given my consent to participate.
Select...
I am HIV positive with a viral load under 200 copies/mL.

HOLA-CD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants completing the study
Secondary outcome measures
Changes in adiponectin
Changes in anxiety as measured by the GAD-7
Changes in biomarkers of cognition
+6 more

HOLA-CD Trial Design

1Treatment groups
Experimental Treatment
Group I: HOLA GroupExperimental Treatment1 Intervention
Participants in this group will receive a multicomponent intervention for 16 weeks.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
897 Previous Clinical Trials
409,230 Total Patients Enrolled
2 Trials studying Cognitive Decline
107 Patients Enrolled for Cognitive Decline
National Institute on Minority Health and Health Disparities (NIMHD)NIH
373 Previous Clinical Trials
1,214,426 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,004,140 Total Patients Enrolled
31 Trials studying Cognitive Decline
22,774 Patients Enrolled for Cognitive Decline

Media Library

Happy Older Latinos are Active (HOLA) Clinical Trial Eligibility Overview. Trial Name: NCT04791709 — N/A
Cognitive Decline Research Study Groups: HOLA Group
Cognitive Decline Clinical Trial 2023: Happy Older Latinos are Active (HOLA) Highlights & Side Effects. Trial Name: NCT04791709 — N/A
Happy Older Latinos are Active (HOLA) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04791709 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants can be enrolled in this research trial?

"Indeed, clinicaltrials.gov has the latest information regarding this medical study's recruitment status. It was posted on February 1st 2022 and revised lastly on November 14th 2022. 30 volunteers are needed from a single location to complete the trial."

Answered by AI

Are there any open slots still available in this clinical experiment?

"Per details on clinicaltrials.gov, this medical experiment is actively seeking volunteers; it was published on February 1st 2022 and the information has been updated most recently on November 14th 2022."

Answered by AI
~5 spots leftby Aug 2024